Edesa Biotech, Inc.

Healthcare · Biotechnology · Canada

Last price 2.57 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 34.72M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07,...